SynthesisMarine biotechnology (New York, N.Y.)2025
Exploring Marine-Derived Polysaccharides Through In Vitro and Zebrafish In Vivo Assays: Initial Trends of A Novel Approach to Drug Screening.
Synthesis in Marine biotechnology (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Study of the Cytotoxic and Wound Healing Activity of Polysaccharides fromMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The sulfated polysaccharides derived from marine species have attracted attention for their nutraceutical and pharmaceutical potential. Initially examined in cell culture, many labs have further tested their activity in in vivo rodent assays. Zebrafish embryos have been recently proposed as an alternative model species to test anti-inflammatory, fungicidal, immunomodulatory, antioxidant, antitumour, or toxicity effects with significant success. In this article, we systematically review by PRISMA strategy the assays that use zebrafish to evaluate potential nutraceutical and pharmaceutical applications of polysaccharides from more than 30 marine algal species. Effects against cancer, inflammation, and oxidative stress or over regeneration capacity, immunomodulation, and photoprotection in zebrafish are here compared. From this review, some polysaccharides appear as safe antitumour compounds (e.g. neutral S. skottsbergii-derived fraction over G-361 melanoma) while others show significant toxicity to embryos. The current bibliography shows a clear trend to use in parallel zebrafish larvae and in vitro assays to test the effects of polysaccharide fractions recovered from a variety of bioprocesses from different marine algae-derived biomass. Its potential application in the pharmacology and nutraceutical industry is discussed.
Indexed as
Identifiers
41283939What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.